Mucus Relief Tablet
FDA Label NDC 57896-794

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Geri-care Pharmaceuticals, Corp for the product Mucus Relief (NDC 57896-794). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient (In Each Tablet)

Guaifenesin 400 mg

Purpose

Expectorant

Uses

helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive to rid the bronchial passageways
of bothersome mucus

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • take with full glass of water
  • do not exceed recommended dose
    • adults and children 12 years
    of age and over
    		1 tablet, every 4 hours, while
    symptoms persist • do not
    exceed 6 doses in 24 hours
    children under 12 years of age
    		do not use

Other Information

• Tamper Evident: do not use if imprinted safety seal under cap is broken or missing.

• store at controlled room temperature 20 °-25°C (68°-77°F)

Inactive Ingredients

cellulose, magnesium stearate, maltodextrin, povidone, silica, sodium starch glycolate, stearic acid.

* Please review the disclaimer below.